Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
- Yoonhee Nam
- , Harim Koo
- , Yingxi Yang
- , Sang Shin
- , Zhihan Zhu
- , Donggeon Kim
- , Hee Jin Cho
- , Quanhua Mu
- , Seung Won Choi
- , Jason K. Sa
- , Yun Jee Seo
- , Yejin Kim
- , Kyoungmin Lee
- , Jeong Woo Oh
- , Yong Jun Kwon
- , Woong Yang Park
- , Doo Sik Kong
- , Ho Jun Seol
- , Jung Il Lee
- , Chul Kee Park
- Hong Kong University of Science and Technology
- Samsung Medical Center, Sungkyunkwan university
- Korea University
- National Cancer Center Korea
- Columbia University
- Sungkyunkwan University
- Seoul National University
- Hong Kong Center for Neurodegenerative Diseases Limited
- HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations